Market closed

Kenvue /$KVUE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Kenvue

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Ticker

$KVUE

Trading on

NYSE

Industry

Personal Care Products

Employees

22,000

Kenvue Metrics

BasicAdvanced
$41B
Market cap
39.10
P/E ratio
$0.55
EPS
-
Beta
$0.81
Dividend rate
3.79%
Dividend yield
$41B
$24.05
$17.67
14M
$0.81
0.999
0.58
67.071
82.929
144.92%
5.35%
6.76%
9.88%
39.102
2.677
3.89
-5.49
29.54
3.75%
3.79%
-0.55%
-41.30%

What the Analysts think about Kenvue

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Kenvue stock.

Kenvue Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kenvue Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KVUE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kenvue stock?

Kenvue (KVUE) has a market cap of $41B as of December 21, 2024.

What is the P/E ratio for Kenvue stock?

The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 39.1 as of December 21, 2024.

Does Kenvue stock pay dividends?

Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is $0.81 and the yield is 3.79%. Kenvue has a payout ratio of 144.92% on a trailing twelve-month basis.

When is the next Kenvue dividend payment date?

The next Kenvue (KVUE) dividend payment date is unconfirmed.

What is the beta indicator for Kenvue ?

Kenvue (KVUE) does not currently have a Beta indicator.